Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) EBITDA Margin (2020 - 2024)

Historic EBITDA Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 58.17%.

  • ImageneBio's EBITDA Margin rose 15876500.0% to 58.17% in Q3 2024 from the same period last year, while for Dec 2024 it was 1834.29%, marking a year-over-year decrease of 10110600.0%. This contributed to the annual value of 736.36% for FY2023, which is 2911900.0% down from last year.
  • According to the latest figures from Q3 2024, ImageneBio's EBITDA Margin is 58.17%, which was up 15876500.0% from 3324.43% recorded in Q4 2023.
  • ImageneBio's EBITDA Margin's 5-year high stood at 13.81% during Q4 2021, with a 5-year trough of 40081.54% in Q4 2020.
  • Moreover, its 5-year median value for EBITDA Margin was 292.02% (2023), whereas its average is 3205.03%.
  • In the last 5 years, ImageneBio's EBITDA Margin skyrocketed by 400953500bps in 2021 and then tumbled by -51270700bps in 2022.
  • ImageneBio's EBITDA Margin (Quarter) stood at 40081.54% in 2020, then soared by 100bps to 13.81% in 2021, then plummeted by -2108bps to 277.32% in 2022, then plummeted by -1099bps to 3324.43% in 2023, then soared by 98bps to 58.17% in 2024.
  • Its last three reported values are 58.17% in Q3 2024, 3324.43% for Q4 2023, and 1645.82% during Q3 2023.